INNOVATE ORTHOPAEDICS LIMITEDActive

Company number 09203933Private limited companyIncorporated 2014

Key figures

£794,306+30.4%
Net assets 2025
+67.1%
Average annual growth 2020–2025
0200 k400 k600 k800 k20202021202320242025

INNOVATE ORTHOPAEDICS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m20202021202320242025

Dividends

from the accounts
2025

Dividends paid in the financial year: £40,000 (18% of the profit for the year).

Filed accounts2020–2025
20202021202320242025
Profit for the year————224,947
Cash at bank and in hand170,847161,188380,152492,201449,720
Total assets427,149454,415722,021875,094870,758
Total liabilities325,324308,517303,980268,831131,830
Net assets / total equity101,825157,313423,945609,359794,306
Average number of employees44400
Dividends paid————40,000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: INNOVATE ORTHOPAEDICS LIMITED

Company

INNOVATE ORTHOPAEDICS LIMITED is a private limited company registered with Companies House under company number 09203933. It was incorporated on 4 Sep 2014. Its status is active. The registered office is in Huddersfield (HD7). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Profit for the year was £224,947. Net assets were £794,306, up 30.4% on the previous year. Cash at bank and in hand was £449,720. Total assets were £870,758 and total liabilities £131,830. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2025).

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 18 Sep 2027.